Annie Singh, PA
Physician Assistant · Newark
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 3 carriers
- Offices
- 3
Offices
3 locations
Plans that list them
5 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Annie Singh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$20,111
Medicare paid this office $20,111 for 77 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of skin growth, 1-14 growths | 32 | $4,972 | $94 |
| Short return visit (20+ min) | 39 | $3,738 | $63 |
| Return visit (30+ min) | 34 | $3,610 | $90 |
| Destruction of precancer skin growth, 1 growth | 30 | $2,055 | $42 |
| Biopsy of related skin growth, first growth | 18 | $1,410 | $71 |
See all 8 services
| Destruction of skin growth, 1-14 growths | 32 | $4,972 | $94 |
| Short return visit (20+ min) | 39 | $3,738 | $63 |
| Return visit (30+ min) | 34 | $3,610 | $90 |
| Destruction of precancer skin growth, 1 growth | 30 | $2,055 | $42 |
| Biopsy of related skin growth, first growth | 18 | $1,410 | $71 |
| New patient visit (45+ min) | 11 | $1,340 | $122 |
| Destruction of precancer skin growth, 2-14 growths | 28 | $1,165 | $6 |
| New patient visit (30+ min) | 12 | $901 | $75 |
Procedures Medicare counted
| Removal of skin lesions | 33 | More than 69% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
77 Original Medicare patients in 2024. Average age 73 · Women 65% · Health risk score 0.85. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 60% · Diabetes 22% · Atrial fibrillation 16% · Depression 16% · Coronary heart disease 14% · Chronic kidney disease 14%.
The office billed $43,289, Medicare allowed $28,008 and paid $20,111; for 459 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 77 | 459 | 73 | 0.85 | $43,289 | $20,111 |
| 2023 | 58 | 272 | 71 | 0.98 | $26,771 | $11,982 |
| 2022 | 84 | 327 | 72 | 1.03 | $31,145 | $12,527 |
| 2021 | 15 | 39 | 73 | 0.91 | $4,605 | $2,284 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Short return visit (20+ min) | 33 | $2,595 | $60 |
| Return visit (30+ min) | 16 | $2,078 | $99 |
| Destruction of skin growth, 1-14 growths | 13 | $1,596 | $89 |
| Destruction of precancer skin growth, 1 growth | 23 | $1,328 | $40 |
| New patient visit (30+ min) | 14 | $986 | $70 |
| Destruction of precancer skin growth, 2-14 growths | 21 | $660 | $6 |
2022: 8 services
| Destruction of skin growth, 1-14 growths | 21 | $2,412 | $83 |
| Short return visit (20+ min) | 28 | $2,152 | $61 |
| New patient visit (30+ min) | 23 | $1,636 | $71 |
| Biopsy of related skin growth, first growth | 21 | $1,392 | $63 |
| Destruction of precancer skin growth, 1 growth | 24 | $1,324 | $37 |
| Return visit (30+ min) | 13 | $1,198 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 16 | $578 | $5 |
| Short return visit | 16 | $460 | $27 |
Drugs they prescribed that Part D paid
$116,759
Pharmacies billed $116,759 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 120) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
97 generic and 23 brand-name prescriptions · $116,759 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Taltz | 12 | $80,312 | $6,693 |
| Clobetasol Propionate | 16 | $447 | $28 |
| Ketoconazole | 13 | $203 | $16 |
| Triamcinolone Acetonide | 20 | $57 | $3 |
Year by year
| 2024 | 120 | 47 | 0% (0) | 19% | $116,759 |
| 2023 | 78 | 29 | 0% (0) | 28% | $80,765 |
| 2022 | 70 | 36 | 0% (0) | None | $5,974 |
| 2021 | 32 | 18 | 0% (0) | 0% | $1,482 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Taltz | 12 | $76,492 | $6,374 |
| Ketoconazole | 17 | $260 | $15 |
2022: 1 drug
| Ketoconazole | 18 | $456 | $25 |
Money from drug and device companies
$2,711 in 2025
| 2025 | 18 | 138 | None | $2,711 |
| 2024 | 16 | 197 | None | $5,236 |
| 2023 | 16 | 163 | None | $4,071 |
| 2022 | 10 | 36 | None | $1,320 |
| 2021 | 6 | 10 | None | $486 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $505 | 22 payments
|
| Incyte | Opzelura | $289 | 15 payments
|
| LEO Pharma | Adbry | $268 | 19 payments
|
| Janssen Biotech | Tremfya | $258 | 10 payments
|
| Ucb | Bimzelx | $205 | 13 payments
|
| Lilly USA | Taltz | $200 | 13 payments
|
See all 137 published payments
| Lilly USA | Meals · 2025-10-17 | Taltz | $24 |
| Incyte | Meals · 2025-10-16 | Opzelura | $27 |
| Janssen Biotech | Meals · 2025-10-09 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-10-09 | Tremfya | $5 |
| Sanofi-Aventis U.S. | Education · 2025-10-08 | Dupixent | $90 |
| LEO Pharma | Meals · 2025-10-07 | Adbry | $21 |
| Abbvie | Meals · 2025-10-03 | None | $130 |
| Lilly USA | Meals · 2025-10-02 | Taltz | $24 |
| Lilly USA | Meals · 2025-10-02 | Taltz | $1 |
| Ucb | Meals · 2025-10-01 | Bimzelx | $15 |
| Incyte | Meals · 2025-10-01 | Opzelura | $26 |
| Genzyme | Meals · 2025-09-30 | Dupixent | $20 |
| LEO Pharma | Meals · 2025-09-23 | Adbry | $12 |
| Janssen Biotech | Meals · 2025-09-22 | Tremfya | $29 |
| Ucb | Meals · 2025-09-20 | Bimzelx | $25 |
| Organon | Meals · 2025-09-19 | None | $17 |
| Abbvie | Meals · 2025-09-18 | Rinvoq | $9 |
| Sun Pharmaceutical Industries | Meals · 2025-09-18 | Leqselvi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-09-17 | Dupixent | $12 |
| Abbvie | Meals · 2025-09-16 | Skyrizi | $19 |
| Incyte | Meals · 2025-09-16 | Opzelura | $23 |
| Incyte | Meals · 2025-09-16 | Opzelura | $3 |
| Sun Pharmaceutical Industries | Meals · 2025-09-10 | Winlevi | $14 |
| Ucb | Meals · 2025-09-05 | Bimzelx | $18 |
| Cipher Pharmaceuticals US | Meals · 2025-09-05 | Natroba | $31 |
| Janssen Biotech | Education · 2025-09-03 | Tremfya | $100 |
| Janssen Biotech | Meals · 2025-09-03 | Tremfya | $14 |
| Abbvie | Meals · 2025-09-03 | Skyrizi | $13 |
| Ucb | Meals · 2025-09-03 | Bimzelx | $18 |
| LEO Pharma | Meals · 2025-09-03 | Adbry | $8 |
| Arcutis Biotherapeutics | Meals · 2025-08-26 | Zoryve | $19 |
| Incyte | Meals · 2025-08-22 | Opzelura | $30 |
| Ucb | Meals · 2025-08-21 | Bimzelx | $19 |
| Abbvie | Meals · 2025-08-20 | Skyrizi | $11 |
| Genzyme | Meals · 2025-08-19 | Dupixent | $14 |
| Galderma Laboratories L.P. | Meals · 2025-08-12 | Nemluvio | $17 |
| Lilly USA | Meals · 2025-08-11 | Taltz | $19 |
| Abbvie | Meals · 2025-08-05 | Rinvoq | $13 |
| LEO Pharma | Meals · 2025-08-05 | Adbry | $12 |
| Organon | Meals · 2025-08-04 | None | $16 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $26 |
| Incyte | Meals · 2025-07-15 | Opzelura | $18 |
| LEO Pharma | Meals · 2025-07-15 | Adbry | $18 |
| Abbvie | Meals · 2025-07-11 | Skyrizi | $11 |
| Ucb | Meals · 2025-07-09 | Bimzelx | $15 |
| Genzyme | Meals · 2025-07-09 | Dupixent | $41 |
| Incyte | Meals · 2025-07-01 | Opzelura | $23 |
| Abbvie | Meals · 2025-06-27 | Rinvoq | $26 |
| Ucb | Meals · 2025-06-27 | Bimzelx | $14 |
| Janssen Biotech | Meals · 2025-06-26 | Tremfya | $28 |
| Janssen Biotech | Meals · 2025-06-25 | Tremfya | $19 |
| Genzyme | Meals · 2025-06-24 | Dupixent | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-06-17 | Dupixent | $36 |
| Lilly USA | Meals · 2025-06-13 | Taltz | $21 |
| Lilly USA | Meals · 2025-06-13 | Taltz | $4 |
| Arcutis Biotherapeutics | Meals · 2025-06-13 | Zoryve | $22 |
| Lilly USA | Meals · 2025-06-10 | Taltz | $16 |
| Ucb | Meals · 2025-06-10 | Bimzelx | $14 |
| Incyte | Meals · 2025-06-10 | Opzelura | $25 |
| Pfizer | Meals · 2025-06-10 | Cibinqo | $14 |
| Pfizer | Meals · 2025-06-05 | Cibinqo | $28 |
| Incyte | Meals · 2025-06-04 | Opzelura | $25 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-05-20 | Cabtreo | $23 |
| Almirall | Meals · 2025-05-15 | Klisyri | $20 |
| LEO Pharma | Meals · 2025-05-15 | Adbry | $24 |
| Abbvie | Meals · 2025-05-14 | Skyrizi | $15 |
| Genzyme | Meals · 2025-05-13 | Dupixent | $27 |
| Ucb | Meals · 2025-05-08 | Bimzelx | $16 |
| Abbvie | Meals · 2025-05-07 | Rinvoq | $32 |
| Regeneron Healthcare Solutions | Meals · 2025-05-07 | Dupixent | $16 |
| Ucb | Meals · 2025-05-02 | Bimzelx | $16 |
| LEO Pharma | Meals · 2025-05-02 | Adbry | $24 |
| Arcutis Biotherapeutics | Meals · 2025-05-02 | Zoryve | $29 |
| LEO Pharma | Meals · 2025-04-30 | Adbry | $8 |
| Janssen Biotech | Meals · 2025-04-29 | Tremfya | $25 |
| Janssen Biotech | Meals · 2025-04-28 | Tremfya | $23 |
| LEO Pharma | Meals · 2025-04-25 | Adbry | $20 |
| Lilly USA | Meals · 2025-04-24 | Taltz | $21 |
| Abbvie | Meals · 2025-04-23 | Skyrizi | $8 |
| Janssen Biotech | Meals · 2025-04-21 | Tremfya | $13 |
| Abbvie | Meals · 2025-04-18 | Skyrizi | $13 |
| Arcutis Biotherapeutics | Meals · 2025-04-17 | Zoryve | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-04-16 | Dupixent | $17 |
| Pfizer | Meals · 2025-04-09 | Cibinqo | $20 |
| Genzyme | Meals · 2025-04-03 | Dupixent | $18 |
| Lilly USA | Meals · 2025-04-02 | Taltz | $14 |
| Lilly USA | Meals · 2025-04-02 | Taltz | $3 |
| Incyte | Meals · 2025-04-02 | Opzelura | $14 |
| Abbvie | Meals · 2025-04-01 | Skyrizi | $18 |
| Arcutis Biotherapeutics | Meals · 2025-03-31 | Zoryve | $5 |
| LEO Pharma | Meals · 2025-03-27 | Adbry | $11 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $20 |
| Ucb | Meals · 2025-03-18 | Bimzelx | $16 |
| Galderma Laboratories L.P. | Meals · 2025-03-18 | Nemluvio | $19 |
| Incyte | Meals · 2025-03-15 | Opzelura | $3 |
| Incyte | Meals · 2025-03-15 | Opzelura | $16 |
| Abbvie | Meals · 2025-03-14 | Skyrizi | $9 |
| LEO Pharma | Meals · 2025-03-14 | Adbry | $21 |
| Abbvie | Meals · 2025-03-08 | Skyrizi | $16 |
| Arcutis Biotherapeutics | Meals · 2025-03-07 | Zoryve | $13 |
| Lilly USA | Meals · 2025-03-06 | Taltz | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-03-05 | Dupixent | $35 |
| LEO Pharma | Meals · 2025-02-27 | Adbry | $10 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-21 | Sotyktu | $22 |
| Arcutis Biotherapeutics | Meals · 2025-02-20 | Zoryve | $18 |
| Lilly USA | Meals · 2025-02-17 | Taltz | $17 |
| Incyte | Meals · 2025-02-14 | Opzelura | $17 |
| Almirall | Meals · 2025-02-13 | Klisyri | $14 |
| Genzyme | Meals · 2025-02-12 | Dupixent | $22 |
| Regeneron Healthcare Solutions | Meals · 2025-02-08 | Dupixent | $16 |
| Abbvie | Meals · 2025-02-06 | Rinvoq | $25 |
| LEO Pharma | Meals · 2025-02-06 | Adbry | $10 |
| Incyte | Meals · 2025-02-04 | Opzelura | $17 |
| Galderma Laboratories L.P. | Meals · 2025-02-04 | Nemluvio | $13 |
| Abbvie | Meals · 2025-01-31 | Skyrizi | $16 |
| Arcutis Biotherapeutics | Meals · 2025-01-29 | Zoryve | $13 |
| Ucb | Meals · 2025-01-28 | Bimzelx | $6 |
| Ucb | Meals · 2025-01-28 | Bimzelx | $12 |
| Arcutis Biotherapeutics | Meals · 2025-01-28 | Zoryve | $13 |
| LEO Pharma | Meals · 2025-01-27 | Adbry | $1 |
| LEO Pharma | Meals · 2025-01-27 | Adbry | $6 |
| Incyte | Meals · 2025-01-24 | Opzelura | $21 |
| Arcutis Biotherapeutics | Meals · 2025-01-24 | Zoryve | $19 |
| LEO Pharma | Meals · 2025-01-23 | Adbry | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-01-22 | Dupixent | $36 |
| LEO Pharma | Meals · 2025-01-21 | Adbry | $12 |
| Abbvie | Meals · 2025-01-16 | Skyrizi | $34 |
| LEO Pharma | Meals · 2025-01-16 | Adbry | $13 |
| Arcutis Biotherapeutics | Meals · 2025-01-16 | Zoryve | $9 |
| Almirall | Meals · 2025-01-15 | Klisyri | $30 |
| Regeneron Healthcare Solutions | Meals · 2025-01-14 | Dupixent | $25 |
| Galderma Laboratories L.P. | Meals · 2025-01-14 | Nemluvio | $20 |
| Arcutis Biotherapeutics | Meals · 2025-01-14 | Zoryve | $10 |
| Abbvie | Meals · 2025-01-10 | Skyrizi | $10 |
| LEO Pharma | Meals · 2025-01-10 | Adbry | $27 |
| Lilly USA | Meals · 2025-01-06 | Taltz | $10 |
| Abbvie | Meals · 2025-01-04 | Rinvoq | $30 |
See earlier years (2024, 2023, 2022, 2021)
2024: $5,236
| Arcutis Biotherapeutics | Zoryve | $832 | 27 payments
|
| Lilly USA | Taltz | $800 | 25 payments
|
| Abbvie | Skyrizi | $748 | 33 payments
|
| Incyte | Opzelura | $565 | 21 payments
|
| Genzyme | Dupixent | $352 | 11 payments
|
| Regeneron Healthcare Solutions | Dupixent | $287 | 15 payments
|
| Ucb | Bimzelx | $265 | 9 payments
|
| Janssen Biotech | Tremfya | $248 | 5 payments
|
| LEO Pharma | Adbry | $246 | 16 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $242 | 6 payments
|
| Almirall | Klisyri | $204 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $196 | 9 payments
|
| Novartis Pharmaceuticals | Cosentyx | $135 | 8 payments
|
| Dermavant Sciences | Vtama | $78 | 4 payments
|
| Pfizer | Cibinqo | $20 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $19 | 1 payment
|
2023: $4,071
| Genzyme | Dupixent | $764 | 22 payments
|
| Regeneron Healthcare Solutions | Dupixent | $484 | 18 payments
|
| Abbvie | Skyrizi | $453 | 24 payments
|
| Incyte | Opzelura | $437 | 14 payments
|
| Arcutis Biotherapeutics | None | $431 | 18 payments
|
| LEO Pharma | Adbry | $360 | 23 payments
|
| Sun Pharmaceutical Industries | Winlevi | $279 | 11 payments
|
| Lilly USA | Taltz | $226 | 11 payments
|
| Dermavant Sciences | Vtama | $200 | 8 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $186 | 7 payments
|
| Janssen Biotech | Tremfya | $102 | 2 payments
|
| Ucb | Bimzelx | $40 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $35 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $27 | 1 payment
|
| Galderma Laboratories L.P. | Epsolay | $25 | 1 payment
|
| Biofrontera | Ameluz | $23 | 1 payment
|
2022: $1,320
| Regeneron Healthcare Solutions | Dupixent | $296 | 7 payments
|
| Genzyme | Dupixent | $195 | 5 payments
|
| Abbvie | Skyrizi | $185 | 7 payments
|
| Incyte | Opzelura | $160 | 4 payments
|
| Journey Medical | Qbrexza | $144 | 4 payments
|
| Allergan | Botox | $130 | 1 payment
|
| Galderma Laboratories L.P. | Twyneo | $125 | 4 payments
|
| Sun Pharmaceutical Industries | Winlevi | $35 | 2 payments
|
| EPI Health | Cloderm | $27 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $21 | 1 payment
|
2021: $486
| AbbVie | Skyrizi | $154 | 3 payments
|
| Galderma Laboratories L.P. | Aklief | $118 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $113 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $55 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $23 | 1 payment
|
| Genzyme | Dupixent | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 88.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1609466051
- Licence
- CA PA58936
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 4300 El Camino Real, Ste 100, Los Altos, CA, 94022
- NPI first listed
- 2021-01-20
- NPI last updated
- 2021-04-15
- NPI record certified
- 2021-04-15
This is when the NPI record was last certified, not a medical board exam.